NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells
Authors
Keywords
T cell activation, NAMPT, TUB, NAD, supplement, CAR-T, PD-1, cancer immunotherapy
Journal
Cell Reports
Volume 36, Issue 6, Pages 109516
Publisher
Elsevier BV
Online
2021-08-11
DOI
10.1016/j.celrep.2021.109516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
- (2020) Alexander Duscha et al. CELL
- Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
- (2020) Yingjie Bian et al. NATURE
- NAD+ metabolism governs the proinflammatory senescence-associated secretome
- (2019) Timothy Nacarelli et al. NATURE CELL BIOLOGY
- Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
- (2019) Y Fradet et al. ANNALS OF ONCOLOGY
- NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
- (2019) Sudhir Chowdhry et al. NATURE
- Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function
- (2019) Will Bailis et al. NATURE
- NAD metabolism: Implications in aging and longevity
- (2018) Keisuke Yaku et al. AGEING RESEARCH REVIEWS
- MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data
- (2018) Jasmine Chong et al. BIOINFORMATICS
- Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
- (2018) Ling Liu et al. Cell Metabolism
- Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation
- (2018) Wanjing Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic regulation of transcription through compartmentalized NAD+biosynthesis
- (2018) Keun Woo Ryu et al. SCIENCE
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- Glucose feeds the TCA cycle via circulating lactate
- (2017) Sheng Hui et al. NATURE
- Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
- (2017) Julia Joung et al. Nature Protocols
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
- (2016) Michael D. Buck et al. CELL
- HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer
- (2016) Gaofeng Fan et al. GENES & DEVELOPMENT
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
- (2016) Nicole E. Scharping et al. IMMUNITY
- Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8 + T Cell Exhaustion
- (2016) Bertram Bengsch et al. IMMUNITY
- Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
- (2016) M. Peng et al. SCIENCE
- NAMPT-Mediated NAD + Biosynthesis Is Essential for Vision In Mice
- (2016) Jonathan B. Lin et al. Cell Reports
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
- (2015) Soranobu Ninomiya et al. BLOOD
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- NAD+ in aging, metabolism, and neurodegeneration
- (2015) E. Verdin SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- CD38 and CD157: A long journey from activation markers to multifunctional molecules
- (2013) Valeria Quarona et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- NAD+Levels Control Ca2+Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes
- (2012) Mirko Magnone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
- (2011) M. Pittelli et al. MOLECULAR PHARMACOLOGY
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tubby family proteins
- (2011) Saikat Mukhopadhyay et al. GENOME BIOLOGY
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now